Literature DB >> 33855117

Quantitative Measurement of Mucolytic Enzymes in Fecal Samples.

Shahanshah Khan1, Hasan Zaki1.   

Abstract

The mucus layer in the gastrointestinal tract covers the apical surface of intestinal epithelial cells, protecting the mucosal tissue from enteric pathogen and commensal microorganisms. The mucus is primarily composed of glycosylated protein called mucins, which are produced by goblet cells, a type of columnar epithelial cells in the intestinal tract. Defective mucin barrier facilitates infection caused by enteric pathogen and triggers inflammation due to invasion of commensal or opportunistic pathogens into the intestinal epithelial mucosa. Several bacterial species in the gut produce enzymes that are capable of degradation of the mucus. Defective mucin production or increased abundance of mucolytic bacteria are clinically linked to inflammatory bowel disease. Measurement of mucolytic enzymes in the feces, therefore, can be implicated in clinical and experimental research on intestinal disorders. Here, we describe a step-by-step procedure for the measurement of the mucolytic enzyme activity in fecal samples.
Copyright © 2021 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Mucin; Mucolytic enzymes; Mucus; Mucus degrading bacteria

Year:  2021        PMID: 33855117      PMCID: PMC8032484          DOI: 10.21769/BioProtoc.3956

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  22 in total

Review 1.  Microbial adhesins to gastrointestinal mucus.

Authors:  Nathalie Juge
Journal:  Trends Microbiol       Date:  2011-11-14       Impact factor: 17.079

2.  Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria.

Authors:  Chin Wen Png; Sara K Lindén; Kristen S Gilshenan; Erwin G Zoetendal; Chris S McSweeney; Lindsay I Sly; Michael A McGuckin; Timothy H J Florin
Journal:  Am J Gastroenterol       Date:  2010-07-20       Impact factor: 10.864

3.  The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria.

Authors:  Malin E V Johansson; Mia Phillipson; Joel Petersson; Anna Velcich; Lena Holm; Gunnar C Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

4.  A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility.

Authors:  Mahesh S Desai; Anna M Seekatz; Nicole M Koropatkin; Nobuhiko Kamada; Christina A Hickey; Mathis Wolter; Nicholas A Pudlo; Sho Kitamoto; Nicolas Terrapon; Arnaud Muller; Vincent B Young; Bernard Henrissat; Paul Wilmes; Thaddeus S Stappenbeck; Gabriel Núñez; Eric C Martens
Journal:  Cell       Date:  2016-11-17       Impact factor: 41.582

Review 5.  Mucins in inflammatory bowel diseases and colorectal cancer.

Authors:  Yong H Sheng; Sumaira Z Hasnain; Timothy H J Florin; Michael A McGuckin
Journal:  J Gastroenterol Hepatol       Date:  2012-01       Impact factor: 4.029

Review 6.  Mucin dynamics and enteric pathogens.

Authors:  Michael A McGuckin; Sara K Lindén; Philip Sutton; Timothy H Florin
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

Review 7.  Role of mucus layers in gut infection and inflammation.

Authors:  Gunnar C Hansson
Journal:  Curr Opin Microbiol       Date:  2011-12-14       Impact factor: 7.934

Review 8.  Structure and function of the polymeric mucins in airways mucus.

Authors:  David J Thornton; Karine Rousseau; Michael A McGuckin
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

9.  Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria.

Authors:  A P Corfield; S A Wagner; J R Clamp; M S Kriaris; L C Hoskins
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 10.  The gut microbiota shapes intestinal immune responses during health and disease.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.